Olli T. Raitakari

Olli T. Raitakari

Auto-generated profile, based on publicly available information

Olli T. Raitakari

59Centre for Population Health Research, Department of Clinical Physiology and Nuclear Medicine, InFLAMES Research Flagship, Turku University Hospital and University of Turku, Turku, Finland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2003 in JAMA
Verified
Journal Article
Open access
PDF file
OROlli T. Raitakari
Olli T. Raitakari
MJMarkus Juonala
Markus Juonala
MKMika Kähönen
Mika Kähönen
LTLeena Taittonen
Leena Taittonen
TLTomi Laitinen
Tomi Laitinen
JVJorma S. A. Viikari
Jorma S. A. Viikari
Atherosclerosis is thought to begin in childhood and to develop silently for decades before clinical events such as myocardial infarction or stroke occur. Autopsy studies in children and adolescents have confirmed the presence of preclinical atherosclerotic lesions and shown their associations with antemortem vascular risk factors.1-3 Studies using ultrasound imaging have demonstrated atherosclerotic wall thickening in the arteries of children with risk factors.4-6 Longitudinal studies have shown that risk factor levels measured in childhood are predictive of risk factor levels in adulthood.7-9 Moreover, levels of serum cholesterol measured in young adult men have been associated with cardiovascular disease in midlife.10,11 Although these observations suggest that risk factors identified in childhood are predictive of adult atherosclerosis, there is only limited direct evidence of this relationship.12,13

7 February 2008 in International Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
OROlli T Raitakari
Olli T Raitakari
MJMarkus Juonala
Markus Juonala
TRTapani Rönnemaa
Tapani Rönnemaa
LKLiisa Keltikangas-Järvinen
Liisa Keltikangas-Järvinen
LRLeena Räsänen
Leena Räsänen
JVJorma Sa Viikari
Jorma Sa Viikari
In Finland, coronary heart disease (CHD) incidence was very high in the 1960s and 1970s.1 In line with this high incidence, the Seven Countries Study showed that the level of serum cholesterol in Finns was also the highest among the investigated countries in the 1960s.2 Because several studies indicated that the atherosclerotic process starts early in life, and in accord with the World Health Organization Recommendation of 19783 which stated that studies assessing atherosclerosis precursors in children should be initiated, a program was launched in Finland in the late 1970s to study cardiovascular risk in the youth.4–6 The Cardiovascular Risk in Young Finns Study was designed as a collaborative effort between five university departments of medical schools (i.e. in Helsinki, Kuopio, Oulu, Tampere and Turku) and several other institutions in Finland. The aim was to study the levels of CHD risk factors and their determinants in children and adolescents of various ages in different parts of the country. Two pilot studies were carried out in 1978 (N = 264, age 8 years) and in 1979 (N = 634, aged 3, 12 and 17 years).6,7 The first main cross-sectional (baseline) study was performed in 1980. The baseline study included 3596 children and adolescents aged 3, 6, 9, 12, 15 and 18 years.8 Between 1980 and 1992, these cohorts were followed up at 3-year intervals. The latest examination of the Cardiovascular Risk in Young Finns Study was performed in 2001, when the participants were young adults, aged 24–39 years. At the time of writing, the 27-year (i.e. 27 years since the start of the study when the participants are aged 30–45 years) follow-up field studies are being conducted, and will be completed in the beginning of 2008.

13 December 2016 in BMC Medicine
Verified
Journal Article
Open access
PDF file
QWQin Wang
Qin Wang
PWPeter Würtz
Peter Würtz
KAKirsi Auro
Kirsi Auro
VMVille-Petteri Mäkinen
Ville-Petteri Mäkinen
AKAntti J. Kangas
Antti J. Kangas
MAMika Ala-Korpela
Mika Ala-Korpela
Pregnancy triggers well-known alterations in maternal glucose and lipid balance but its overall effects on systemic metabolism remain incompletely understood. Detailed molecular profiles (87 metabolic measures and 37 cytokines) were measured for up to 4260 women (24–49 years, 322 pregnant) from three population-based cohorts in Finland. Circulating molecular concentrations in pregnant women were compared to those in non-pregnant women. Metabolic profiles were also reassessed for 583 women 6 years later to uncover the longitudinal metabolic changes in response to change in the pregnancy status. Compared to non-pregnant women, all lipoprotein subclasses and lipids were markedly increased in pregnant women. The most pronounced differences were observed for the intermediate-density, low-density and high-density lipoprotein triglyceride concentrations. Large differences were also seen for many fatty acids and amino acids. Pregnant women also had higher concentrations of low-grade inflammatory marker glycoprotein acetyls, higher concentrations of interleukin-18 and lower concentrations of interleukin-12p70. The changes in metabolic concentrations for women who were not pregnant at baseline but pregnant 6 years later (or vice versa) matched (or were mirror-images of) the cross-sectional association pattern. Cross-sectional results were consistent across the three cohorts and similar longitudinal changes were seen for 653 women in 4-year and 497 women in 10-year follow-up. For multiple metabolic measures, the changes increased in magnitude across the three trimesters. Pregnancy initiates substantial metabolic and inflammatory changes in the mothers. Comprehensive characterisation of normal pregnancy is important for gaining understanding of the key nutrients for fetal growth and development. These findings also provide a valuable molecular reference in relation to studies of adverse pregnancy outcomes.

5 January 2022 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
OROlli Raitakari
Olli Raitakari
KPKatja Pahkala
Katja Pahkala
CMCostan G. Magnussen
Costan G. Magnussen

14 February 2017 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
TNTapio Nevalainen
Tapio Nevalainen
LKLaura Kananen
Laura Kananen
SMSaara Marttila
Saara Marttila
JJJuulia Jylhävä
Juulia Jylhävä
NMNina Mononen
Nina Mononen
MHMikko Hurme
Mikko Hurme
Human aging is associated with profound changes in one of the major epigenetic mechanisms, DNA methylation. Some of these changes occur in a clock-like fashion, i.e., correlating with the calendar age of an individual, thus providing a new aging biomarker. Some reports have identified factors associated with the acceleration of the epigenetic age. However, it is also important to analyze the temporal changes in the epigenetic age, i.e., the duration of the observed acceleration, and the effects of the possible therapeutic and lifestyle modifications. To address this issue, we determined the epigenetic age for a cohort of 183 healthy individuals using blood samples derived from two time points that were 25 years apart (between 15–24 and 40–49 years of age). Additionally, we also determined the epigenetic ages of 119 individuals in a cohort consisting of 90-year-old participants (nonagenarians). These were determined by using the Horvath algorithm based on the methylation level of 353 CpG sites. The data are indicated as the deviation of the epigenetic age from the calendar age (calendar age minus epigenetic age = delta age, ΔAGE). As obesity is often associated with accelerating aging and degenerative phenotypes, the correlation of the body mass index (BMI) with the ΔAGE was analyzed in the following three age groups: young adults, middle-aged, and nonagenarian. The data showed that BMI is associated with decreased ΔAGE, i.e., increased epigenetic age, in middle-aged individuals. This effect is also seen during the 25-year period from early adulthood to middle age, in which an increase in the BMI is significantly associated with a decrease in the ΔAGE. We also analyzed the association between BMI and epigenetic age in young and elderly individuals, but these associations were not significant. Taken together, the main finding on this report suggests that association between increased BMI and accelerated epigenetic aging in the blood cells of middle-aged individuals can be observed, and this effect is also detectable if the BMI has increased in adulthood. The fact that the association between BMI and epigenetic age can only be observed in the middle-aged group does not exclude the possibility that this association could be present throughout the human lifespan; it might just be masked by confounding factors in young adults and nonagenarian individuals.

22 March 2004 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
MJM. Juonala
M. Juonala
JVJ. S. A. Viikari
J. S. A. Viikari
NHN. Hutri‐Kähönen
N. Hutri‐Kähönen
MPM. Pietikäinen
M. Pietikäinen
EJE. Jokinen
E. Jokinen
ORO. T. Raitakari
O. T. Raitakari
: Objectives.  The Cardiovascular Risk in Young Finns Study is an on‐going multicentre study of atherosclerosis precursors in Finnish children and young adults. We have collected risk factor data in the 21‐year follow‐up performed in 2001. The aims of this analysis were to examine the levels, secular trends and east–west difference in risk factors amongst young adults.Design.  Population based follow‐up study.Subjects.  A total of 2283 participants aged 24–39 years in 2001 (63.5% of the original cohort).Main outcome measures.  Levels of serum lipids, apolipoproteins, blood pressure and smoking.Results.  The mean serum total cholesterol, low density lipoprotein cholesterol, high density lipoprotein (HDL) cholesterol and triglyceride concentrations in 24–39‐year‐old adults were 5.16, 3.27, 1.29 and 1.34 mmol L−1, respectively. Total cholesterol (5.21 vs. 5.12 mmol L−1, P = 0.046), HDL cholesterol (1.31 vs. 1.28 mmol L−1, P = 0.027), systolic blood pressure (118 vs. 115 mmHg, P < 0.0001) and diastolic blood pressure (72 vs. 70 mmHg, P < 0.0001) were higher in subjects originating from eastern Finland compared with those from western Finland. Significant secular trends between 1986 and 2001 in 24‐year‐old subjects (n = 783) included an increase in serum triglycerides and body mass index (BMI), a decrease in blood pressure and HDL cholesterol and a modest 5% decrease in total cholesterol levels.Conclusions.  During the past 15 years, BMI and triglyceride levels have increased in young adults in Finland. At the same time, the reduction in cholesterol concentration has been slow. Consistent with persistent regional differences in cardiovascular morbidity within Finland, our data demonstrate significant differences in the levels of cardiovascular risk factors between subjects originating from eastern and western Finland.